ezetimibe (Zydus Pharmaceuticals (USA) Inc.)
Welcome to the PulseAid listing for the ezetimibe drug offered from Zydus Pharmaceuticals (USA) Inc.. This Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Zydus Pharmaceuticals (USA) Inc. |
| NON-PROPRIETARY NAME: | ezetimibe |
| SUBSTANCE NAME: | EZETIMIBE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-08-09 |
| END MARKETING DATE: | 0000-00-00 |
ezetimibe HUMAN PRESCRIPTION DRUG Details:
| Item Description | ezetimibe from Zydus Pharmaceuticals (USA) Inc. |
| LABELER NAME: | Zydus Pharmaceuticals (USA) Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2017-08-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68382-773_f94b0d30-9b8a-4ec4-a185-6b817b68809f |
| PRODUCT NDC: | 68382-773 |
| APPLICATION NUMBER: | ANDA204331 |
Other EZETIMIBE Pharmaceutical Manufacturers / Labelers:
